The Myositis Clinical Trials Consortium: an international collaborative initiative to promote clinical trials in adult and juvenile myositis
Authors' conclusion
Through experienced leadership, strategic collaborations, and interdisciplinary discussions, MCTC will establish standards for IIM clinical trial design, protocols, and outcome measures in myositis.
Study context
- Population
- Myositis investigators globally (pilot Myositis Investigators' Information Survey)
- Participants
- 173 myositis investigators
- Outcome
- Pilot Myositis Investigators' Information Survey
Methodological detailsinternational collaborative initiative, Myositis Clinical Trials Consortium (MCTC) formed as an international alliance to facilitate, promote, coordinate and conduct clinical trials in idiopathic inflammatory myopathies (IIM); Steering Committee, Core Group and Paediatric Subcommittee of myositis experts and junior investigators
- International collaborative initiative
- MCTC formed as an international alliance to facilitate, promote, coordinate and conduct clinical trials in IIM; Steering Committee, Core Group and Paediatric Subcommittee of myositis experts and junior investigators
Main finding
As reported in the abstract
- Considerable variability in proficiency with outcome measures
- Geographic disparities in patient recruitment
- Significant disconnect between investigators' routine myositis patient load and clinical trial enrolment
Observational data: associations, not effects.
Original publication
The Myositis Clinical Trials Consortium: an international collaborative initiative to promote clinical trials in adult and juvenile myositis. Clin Exp Rheumatol. Published 15 November 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →